Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$4.35 – $6.93
25% from low
Exchange
OTC Link
ADRC
Borrow rate
14.89%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.55B | $14.60B | $13.76B | $14.55B | $16.87B | $18.12B | $18.02B | $16.39B |
| Cost of revenue | $7.88B | $8.46B | $8.15B | $9.11B | $10.52B | $11.32B | $11.27B | $10.26B |
| Gross profit | $5.68B | $6.14B | $5.61B | $5.44B | $6.35B | $6.80B | $6.75B | $6.13B |
| Gross margin | 41.9% | 42.0% | 40.8% | 37.4% | 37.6% | 37.5% | 37.4% | 37.4% |
| R&D | $1.59B | $1.66B | $1.49B | $1.37B | $1.42B | $1.95B | $2.68B | $2.58B |
| Operating income | $1.70B | $1.66B | $1.91B | $1.64B | $1.43B | $2.04B | $890.0M | $425.4M |
| EBITDA | $2.68B | $2.94B | $3.07B | $2.69B | $2.57B | $3.29B | $2.19B | $1.65B |
| Net income | $1.20B | $1.08B | $1.25B | $1.15B | $943.0M | $1.30B | $237.0M | −$509.7M |
| Net margin | 8.8% | 7.4% | 9.1% | 7.9% | 5.6% | 7.2% | 1.3% | -3.1% |
| EPS (diluted) | 3.14 | 2.84 | 3.28 | 3.02 | 2.47 | 3.41 | 0.62 | -1.29 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $17.7B | $4.07 | $3.94–$4.50 | 1 |
| 2028 | $18.6B | $4.45 | $4.30–$4.92 | 1 |
Forward consensus · source: Financial Modeling Prep
ELEKTA B SHS UNSP/ADR
No one on the platform currently holds EKTAY.
No tracked institution reports a position in EKTAY as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-03-06 | $0.1299 | 2026-03-26 |
| 2025-09-08 | $0.1286 | 2025-09-26 |
| 2025-03-07 | $0.1187 | 2025-03-27 |
| 2024-09-09 | $0.1160 | 2024-09-27 |
| 2024-02-26 | $0.1157 | 2024-03-18 |
| 2023-08-25 | $0.1094 | 2023-09-15 |
| Execution date | Ratio |
|---|---|
| 2012-09-25 | 4-for-1 |
No one on the platform has traded EKTAY yet.
| $2.1B |
| — |
| GRRMFGerresheimer AG | $30.50 | -4.98% | $1.1B | — |
| PIAHYPing An Healthcare and Technology Company Limited | $1.92 | +0.00% | $1.0B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 8.2× earnings vs its 3.0× historical median P/E.
Fair value ≈ $1.86 · price $5.00 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.